Discovery Forum Highlights How UC Davis Is at the Center of GLP-1 and Metabolic Health Innovation
Over the past few years, our team has watched the conversation around metabolic health shift dramatically. The rise of GLP-1 drugs like Ozempic and Wegovy has not only transformed how we treat obesity and diabetes, but also redefined how people think about food, nutrition and wellness.
That transformation came into sharp focus during the Discovery Forum: The Science of Metabolic Hormones—Precision Nutrition in the “Ozempic Era,” a two-day event held at Aggie Square and hosted by the UC Davis Innovation Institute for Food and Health (IIFH) in partnership with the UC Davis Office of Innovation and Economic Development (IEDO) and UC Davis Health. Designed for companies, researchers and the investor community, the forum explored the biology of metabolic hormones and what this science means for the future of food, health and consumer trends.